Jefferies Financial Group Inc. Evolus, Inc. Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$7.81 - $11.05 $234 - $331
-30 Reduced 0.01%
500,000 $4.23 Million
Q4 2022

Sep 21, 2023
BUY
$6.52 - $8.95 $3.26 Million - $4.48 Million
500,030 New
500,030 $3.76 Million
Q4 2022

Feb 14, 2023
BUY
$6.52 - $8.95 $3.26 Million - $4.48 Million
500,030 New
500,030 $3.76 Million

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $561M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email